83 related articles for article (PubMed ID: 3141093)
1. Peritonitis prevention in CAPD.
Carozzi S; Lamperi S
Clin Nephrol; 1988; 30 Suppl 1():S45-8. PubMed ID: 3141093
[TBL] [Abstract][Full Text] [Related]
2. Response of CAPD patients with a high incidence of peritonitis to intraperitoneal immunoglobulin therapy.
Carozzi S; Nasini MG; Kunkl A; Cantarella S; Lamperi S
ASAIO Trans; 1988; 34(3):635-9. PubMed ID: 3264176
[TBL] [Abstract][Full Text] [Related]
3. Immunologic patterns in CAPD patients with peritonitis.
Lamperi S; Carozzi S
Clin Nephrol; 1988; 30 Suppl 1():S41-4. PubMed ID: 3052960
[TBL] [Abstract][Full Text] [Related]
4. Opsonic activity of dialysis effluent predicts those at risk of Staphylococcus epidermidis peritonitis.
Coles GA; Alobaidi HM; Topley N; Davies M
Nephrol Dial Transplant; 1987; 2(5):359-65. PubMed ID: 3122114
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide is a marker of peritonitis in patients on continuous ambulatory peritoneal dialysis.
Choi KC; Jeong TK; Lee SC; Kim SW; Kim NH; Lee KY
Adv Perit Dial; 1998; 14():173-9. PubMed ID: 10649719
[TBL] [Abstract][Full Text] [Related]
6. Intraperitoneal immunoglobulin (IG) treatment in prophylaxis of bacterial peritonitis in CAPD.
Lamperi S; Carozzi S; Nasini MG
Biomater Artif Cells Artif Organs; 1987; 15(1):151-9. PubMed ID: 3329538
[TBL] [Abstract][Full Text] [Related]
7. Relationship of IgG, C3 and transferrin with opsonising and bacteriostatic activity of peritoneal fluid from CAPD patients and the incidence of peritonitis.
McGregor SJ; Brock JH; Briggs JD; Junor BJ
Nephrol Dial Transplant; 1987; 2(6):551-6. PubMed ID: 3126457
[TBL] [Abstract][Full Text] [Related]
8. Is interleukin-6 concentration in the dialysate of continuous ambulatory peritoneal dialysis patients a prognostic parameter in peritonitis?
Fiedler R; Schneider I; Fischer K; Deuber HJ; Osten B
Adv Perit Dial; 2001; 17():159-62. PubMed ID: 11510267
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-12 and -18 levels in peritoneal dialysate effluent correlate with the outcome of peritonitis in patients undergoing peritoneal dialysis: implications for the Type I/Type II T-cell immune response.
Wang HH; Lin CY
Am J Kidney Dis; 2005 Aug; 46(2):328-38. PubMed ID: 16112053
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of peritoneal dialysate IgG levels in CAPD patients.
De Vecchi A; Castelnovo C; Failla N; Scalamogna A
Adv Perit Dial; 1990; 6():98-101. PubMed ID: 1982850
[TBL] [Abstract][Full Text] [Related]
11. The effect of dwell time on peritoneal phagocytic defense of chronic peritoneal dialysis patients.
Vlaanderen K; de Fijter CW; Bos HJ; van der Meulen J; Beelen RH; Oe PL; Verbrugh HA
Adv Perit Dial; 1989; 5():151-3. PubMed ID: 2577399
[TBL] [Abstract][Full Text] [Related]
12. Lipopolysaccharide binding protein: a marker for intraperitoneal bacterial infection in patients with CAPD peritonitis.
Schäfer K; Schumann RR; Stöteknuel S; Böhler J; Schollmeyer P; Dobos GJ
Adv Perit Dial; 1997; 13():210-3. PubMed ID: 9360683
[TBL] [Abstract][Full Text] [Related]
13. Opsonic deficiency of peritoneal dialysis effluent in continuous ambulatory peritoneal dialysis.
Keane WF; Comty CM; Verbrugh HA; Peterson PK
Kidney Int; 1984 Mar; 25(3):539-43. PubMed ID: 6376908
[TBL] [Abstract][Full Text] [Related]
14. MCP-1 levels are elevated in peritonitis fluid from CAPD patients due to secretion by peritoneal macrophages.
Sach M; Loetscher P; Burger JA; Knopf HP; Schollmeyer P; Dobos GJ
Adv Perit Dial; 1995; 11():19-23. PubMed ID: 8534702
[TBL] [Abstract][Full Text] [Related]
15. Systemic and intraperitoneal proinflammatory cytokine profiles in patients on continuous ambulatory peritoneal dialysis.
Maksic D; Vasilijic S; Colic M; Stankovic-Popovic V; Bokonjic D
Adv Perit Dial; 2009; 25():50-5. PubMed ID: 19886317
[TBL] [Abstract][Full Text] [Related]
16. Opsonic requirements of Staphylococcus epidermidis.
Clark LA; Easmon CS
J Med Microbiol; 1986 Aug; 22(1):1-7. PubMed ID: 3735386
[TBL] [Abstract][Full Text] [Related]
17. Fas expression on peritoneal macrophages during continuous ambulatory peritoneal dialysis peritonitis.
Chen CY; Wu CY; Tsai TC; Lin WT; Lee WJ; Su CC; Chen HC; Chiang HC
Ren Fail; 2008; 30(3):297-301. PubMed ID: 18350449
[TBL] [Abstract][Full Text] [Related]
18. Specific opsonic activity for staphylococci in peritoneal dialysis effluent during continuous ambulatory peritoneal dialysis.
Nielsen H; Espersen F; Kharazmi A; Antonsen S; Ejlersen E; Joffe P; Pedersen FB
Am J Kidney Dis; 1992 Oct; 20(4):372-5. PubMed ID: 1415206
[TBL] [Abstract][Full Text] [Related]
19. Netilmicin in the treatment of clinical peritonitis in chronic renal failure patients managed by continuous ambulatory peritoneal dialysis.
Neale TJ; Malani J; Humble M
N Z Med J; 1987 Jun; 100(826):374-7. PubMed ID: 3451106
[TBL] [Abstract][Full Text] [Related]
20. Peritoneal dialysis effluent, cytokine levels, and peritoneal mesothelial cell viability in CAPD: a possible relationship.
Carozzi S; Nasini MG; Ravera M; Sanna A; Tirotta A; Lamperi S
Adv Perit Dial; 1997; 13():7-12. PubMed ID: 9360642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
